The role of mitochondria in axonal degeneration and tissue repair in MS. (Q38020826)

27 August 2017

The role of mitochondria in axonal degeneration and tissue repair in MS. (English)

1 reference

27 August 2017

1 reference

J van Horssen

1

1 reference

PubMed ID

22723572

27 August 2017

M E Witte

series ordinal

2

1 reference

PubMed ID

22723572

27 August 2017

O Ciccarelli

series ordinal

3

1 reference

27 August 2017

21 June 2012

1 reference

Multiple Sclerosis Journal

27 August 2017

1 reference

27 August 2017

18

1 reference

27 August 2017

8

1 reference

27 August 2017

1058-1067

1 reference

The molecular basis of neurodegeneration in multiple sclerosis

27 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Multiple sclerosis as a neurodegenerative disease: pathology, mechanisms and therapeutic implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Interferons in relapsing remitting multiple sclerosis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Enhanced number and activity of mitochondria in multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Mitochondrial defects in acute multiple sclerosis lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Increased mitochondrial content in remyelinated axons: implications for multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Newly lesioned tissue in multiple sclerosis--a role for oxidative damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Review: Mitochondria and disease progression in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Proton magnetic resonance spectroscopy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

1H-MRS quantification of tNA and tCr in patients with multiple sclerosis: a meta-analytic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Spinal cord spectroscopy and diffusion-based tractography to assess acute disability in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Quantitative cervical spinal cord 3T proton MR spectroscopy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Correlation of diffusion and metabolic alterations in different clinical forms of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Reduced NAA-levels in the NAWM of patients with MS is a feature of progression. A study with quantitative magnetic resonance spectroscopy at 3 Tesla

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

The relationship between diffuse axonal damage and fatigue in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Spectroscopic axonal damage of the right locus coeruleus relates to selective attention impairment in early stage relapsing-remitting multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Lower levels of glutathione in the brains of secondary progressive multiple sclerosis patients measured by 1H magnetic resonance chemical shift imaging at 3 T.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

MR spectroscopic imaging of glutathione in the white and gray matter at 7 T with an application to multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Neuroimaging of mitochondrial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Unfolding the long-term pathophysiological processes following an acute inflammatory demyelinating lesion of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Energy failure in multiple sclerosis and its investigation using MR techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Spinal cord repair in MS: does mitochondrial metabolism play a role?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Mitochondrial changes within axons in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Assessing neuronal metabolism in vivo by modeling imaging measures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Radical changes in multiple sclerosis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Mitochondria-targeted antioxidants in the treatment of disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Mitochondria-Targeted Antioxidant MitoQ 10 Improves Endothelial Function and Attenuates Cardiac Hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

Reversible decreases in N-acetylaspartate after acute brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458512452924

21 January 2018

Identifiers

DOI

10.1177/1352458512452924

1 reference

27 August 2017

1 reference

PubMed ID

22723572